Jérôme Boursier

28.8k total citations · 9 hit papers
187 papers, 8.1k citations indexed

About

Jérôme Boursier is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Jérôme Boursier has authored 187 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Epidemiology, 113 papers in Hepatology and 20 papers in Surgery. Recurrent topics in Jérôme Boursier's work include Liver Disease Diagnosis and Treatment (158 papers), Liver Disease and Transplantation (68 papers) and Hepatitis C virus research (47 papers). Jérôme Boursier is often cited by papers focused on Liver Disease Diagnosis and Treatment (158 papers), Liver Disease and Transplantation (68 papers) and Hepatitis C virus research (47 papers). Jérôme Boursier collaborates with scholars based in France, United States and United Kingdom. Jérôme Boursier's co-authors include Paul Calès, Frédéric Oberti, Anna Mae Diehl, Victor de Lédinghen, I. Fouchard‐Hubert, Emmanuel Tsochatzis, Laurent Castéra, Maja Thiele, Mariana Verdelho Machado and Salvatore Petta and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Jérôme Boursier

180 papers receiving 8.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

2015 1.1k citations Jérôme Boursier, Mariana Verdelho Machado et al. profile →
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update

2021 950 citations Jérôme Boursier, Laurent Castéra et al. Journal of Hepatology profile →
Determination of reliability criteria for liver stiffness evaluation by transient elastography

2012 486 citations Jérôme Boursier, Victor de Lédinghen et al. profile →
Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy

2015 393 citations Jérôme Boursier, Victor de Lédinghen et al. profile →
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis

2024 353 citations Rohit Loomba, Mark L. Hartman et al. New England Journal of Medicine profile →
Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease

2015 292 citations Mariana Verdelho Machado, Gregory Michelotti et al. PLoS ONE profile →
Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review

2020 226 citations Jenny Lee, Yasaman Vali et al. Liver International profile →
A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures

2023 73 citations Jérôme Boursier, Elisabetta Bugianesi et al. profile →
Metabolic dysfunction-associated steatotic liver disease in adults

2025 53 citations Jérôme Boursier, Rohit Loomba et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jérôme Boursier France	43	6.5k	4.0k	1.6k	1.4k	1.1k	187	8.1k
Yuichiro Eguchi Japan	40	4.8k 0.7×	3.0k 0.7×	1.6k 1.0×	981 0.7×	1.0k 0.9×	178	6.7k
Henning Grønbæk Denmark	43	5.2k 0.8×	2.3k 0.6×	1.4k 0.9×	1.3k 0.9×	1.6k 1.4×	329	8.4k
Cynthia D. Guy United States	38	5.5k 0.8×	2.3k 0.6×	2.2k 1.4×	2.1k 1.5×	1.2k 1.0×	104	7.7k
Satoru Saito Japan	42	4.6k 0.7×	2.5k 0.6×	1.4k 0.9×	1.0k 0.7×	1.5k 1.3×	221	6.8k
Nizar N. Zein United States	44	6.6k 1.0×	5.1k 1.3×	1.4k 0.9×	922 0.7×	2.0k 1.8×	179	9.4k
Masato Yoneda Japan	54	7.0k 1.1×	3.2k 0.8×	2.7k 1.7×	1.8k 1.3×	2.8k 2.4×	309	11.4k
Ricki Bettencourt United States	36	4.0k 0.6×	2.0k 0.5×	1.5k 0.9×	835 0.6×	622 0.6×	77	5.0k
Kento Imajo Japan	40	4.2k 0.6×	2.3k 0.6×	1.5k 0.9×	720 0.5×	821 0.7×	142	5.1k
Mario Rizzetto Italy	43	9.0k 1.4×	6.7k 1.7×	1.9k 1.2×	820 0.6×	1.6k 1.5×	148	10.9k
Luca Miele Italy	40	4.4k 0.7×	1.5k 0.4×	1.9k 1.2×	1.8k 1.3×	961 0.9×	193	6.7k

Countries citing papers authored by Jérôme Boursier

Since Specialization

Citations

This map shows the geographic impact of Jérôme Boursier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Boursier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Boursier more than expected).

Fields of papers citing papers by Jérôme Boursier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Boursier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Boursier. The network helps show where Jérôme Boursier may publish in the future.

Co-authorship network of co-authors of Jérôme Boursier

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Boursier. A scholar is included among the top collaborators of Jérôme Boursier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Boursier. Jérôme Boursier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hartman, Mark L., Rohit Loomba, Eric Lawitz, et al.. (2025). Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with tirzepatide. JHEP Reports. 7(8). 101472–101472. 1 indexed citations

Mouillot, Thomas, Luisa Vonghia, Charlotte Costentin, et al.. (2025). Non-invasive tests for fibrotic MASH for reducing screen failure in therapeutic trials. JHEP Reports. 7(4). 101351–101351. 4 indexed citations

Smati, Sarra, Matthieu Wargny, Jérôme Boursier, et al.. (2024). Prevalence of Liver Steatosis and Fibrosis in Adults With Primary Hypobetaliproteinemia: Results From the HYPOCHOL Study. Clinical Gastroenterology and Hepatology. 23(1). 166–168.e4.

Wargny, Matthieu, Thomas Goronflot, Antoine Rimbert, et al.. (2024). Primary hypocholesterolemia is associated with an increased risk of hepatic complications in the general population. Journal of Hepatology. 80(6). 846–857. 3 indexed citations

Loomba, Rohit, Mark L. Hartman, Eric Lawitz, et al.. (2024). Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis. New England Journal of Medicine. 391(4). 299–310. 353 indexed citations breakdown →

Lapidus, Nathanaël, Jérôme Boursier, Victor de Lédinghen, et al.. (2023). The NAFLD burden on mortality and morbidities in general population: A community‐based longitudinal study (NASH‐CO study). Liver International. 43(10). 2096–2106. 9 indexed citations

Vali, Yasaman, Jenny Lee, Jérôme Boursier, et al.. (2021). FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 10(11). 2415–2415. 42 indexed citations

Canivet, Clémence M., Sarra Smati, Adrien Lannes, et al.. (2021). Awareness of chronic liver diseases, a comparison between diabetologists and general practitioners. Clinics and Research in Hepatology and Gastroenterology. 46(4). 101848–101848. 10 indexed citations

Boursier, Jérôme, Maéva Guillaume, Adrien Lannes, et al.. (2021). Non-invasive diagnosis and follow-up of non-alcoholic fatty liver disease. Clinics and Research in Hepatology and Gastroenterology. 46(1). 101769–101769. 10 indexed citations

10.

Lee, Jenny, Yasaman Vali, Jérôme Boursier, et al.. (2020). Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis. PLoS ONE. 15(9). e0238717–e0238717. 51 indexed citations

11.

Jullian‐Desayes, Ingrid, Wojciech Trzépizur, Jérôme Boursier, et al.. (2020). Obstructive sleep apnea, chronic obstructive pulmonary disease and NAFLD: an individual participant data meta-analysis. Sleep Medicine. 77. 357–364. 27 indexed citations

12.

Lee, Jenny, Yasaman Vali, Jérôme Boursier, et al.. (2020). Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review. Liver International. 41(2). 261–270. 226 indexed citations breakdown →

13.

Wargny, Matthieu, Pierre‐Henri Ducluzeau, Jean‐Michel Petit, et al.. (2018). Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population. Atherosclerosis. 278. 82–90. 32 indexed citations

14.

Dubois, Séverine, Jérôme Boursier, Christophe Aubé, et al.. (2016). Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults. Diabetes & Metabolism. 42(5). 364–367. 22 indexed citations

15.

Boursier, Jérôme, Charlène Brochard, Sandrine Bertrais, et al.. (2014). Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 40(2). 178–188. 33 indexed citations

16.

Miot, Charline, Élodie Beaumont, Dorothée Duluc, et al.. (2014). IL-26 is overexpressed in chronically HCV-infected patients and enhances TRAIL-mediated cytotoxicity and interferon production by human NK cells. Gut. 64(9). 1466–1475. 50 indexed citations

17.

Machado, Mariana Verdelho, Gregory Michelotti, Thiago A. Pereira, et al.. (2014). Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis. Gut. 64(7). 1148–1157. 77 indexed citations

18.

Boursier, Jérôme, Victor de Lédinghen, Vincent Leroy, et al.. (2010). 1046 A NEW FIBROSIS STAGING METHOD PROVIDES VERY ACCURATE NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS WITHOUT LIVER BIOPSY. Journal of Hepatology. 52. S405–S405. 1 indexed citations

19.

Calès, Paul, Jérôme Boursier, Julien Chaigneau, et al.. (2010). Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease. Liver International. 30(9). 1346–1354. 39 indexed citations

20.

Boursier, Jérôme, et al.. (2009). 697 PRECISE AND SIMPLE QUANTITATION OF LIVER STEATOSIS BY MRI IN AN ANIMAL MODEL AND IN PATIENTS WITH NAFLD. Journal of Hepatology. 50. S255–S256. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact